動物用/家畜用ワクチン市場：タイプ別、疾患別、技術別-2025-2030年世界予測

動物用/家畜用ワクチン市場は、2023年に89億6,000万米ドルと評価され、2024年には95億8,000万米ドルに達すると予測され、CAGR 6.94％で成長し、2030年には143億4,000万米ドルに達すると予測されています。

動物用/家畜用ワクチン市場は、動物ヘルスケア産業の中でも重要なセグメントであり、予防接種を通じて動物の感染症を予防することに重点を置いています。これらのワクチンは、家畜、ペット、野生動物の健康と生産性を確保するために不可欠であり、食糧安全保障、公衆衛生、経済的利益を支えています。動物用ワクチンの必要性は、人獣共通感染症の予防、動物福祉の向上、抗生物質への依存度の低減、抗菌薬耐性懸念への対応といった役割によって強調されています。用途は牛、鶏、豚などの家畜から猫や犬などのコンパニオンアニマルまで幅広く、最終用途の主なセクターは畜産、動物病院、研究施設です。

主な成長要因としては、動物性タンパク質に対する需要の増加、ペット飼育率の上昇、動物福祉と疾病予防への関心の高まりなどが挙げられます。さらに、ワクチン接種を促進する政府の取り組みや、DNAワクチンや組み換えワクチンのような新規ワクチン開発のためのバイオテクノロジーの進歩も、市場拡大に大きく寄与しています。より効果的で、手頃な価格で、容易に投与可能なワクチンの創出を目指す研究開発への意識と投資の高まりから、潜在的なビジネスチャンスが生まれます。こうした機会を生かすための調査には、革新的な研究への投資、流通網の強化、都市化と可処分所得が増加する新興市場への注力などが含まれます。

しかしながら、厳しい規制要件、ワクチン市場開拓に伴う高コスト、特定地域における認知度の不足といった課題が、市場成長の妨げとなっています。また、新興経済諸国における限られたコールドチェーン・インフラと相まって、安定性と保管の問題も大きな障壁となっています。技術革新と研究が必要とされる分野には、耐熱性ワクチンの開発、経口ワクチンやナノ粒子ベースワクチンなどの代替デリバリーシステム、免疫反応を高める新規アジュバントなどがあります。競合情勢や規制状況、消費者の嗜好を理解することは、成長を目指す企業にとって極めて重要です。市場はダイナミックな傾向にあり、絶え間ない技術革新と規制の変更が市場の進化を形成し、課題と新たな成長機会の両方をもたらしています。

市場力学：急速に進化する動物用/家畜用ワクチン市場の主要市場インサイトを公開

動物用/家畜用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルおよび家畜の飼育数の増加
  • 経済国における動物医療施設の改善
  • 動物の慢性疾患や事故による怪我の発生率の増加
• 市場抑制要因
  • ワクチンの保管コストの高さ
• 市場機会
  • 動物用ワクチンの研究開発への投資の増加
  • ペット保険の利用可能性の増加
• 市場の課題
  • 不十分な監視・報告システム

ポーターの5つの力動物用/家畜用ワクチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用/家畜用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、動物用/家畜用ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用/家畜用ワクチン市場における競合情勢の把握

動物用/家畜用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用/家畜用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用/家畜用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用/家畜用ワクチン市場における成功への道筋を描く

動物用/家畜用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットや家畜の飼育数の増加
    • 経済における獣医ケア施設の改善
    • 動物の慢性疾患や事故による傷害の発生率の上昇
  • 抑制要因
    • ワクチンの保管コストが高い
  • 機会
    • 獣医用ワクチンの研究開発への投資増加
    • ペット保険の利用可能性が拡大
  • 課題
    • 不十分な監視および報告システム
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用/家畜用ワクチン市場：タイプ別

• 水産養殖ワクチン
• ペット用ワクチン
• 家畜ワクチン
• 豚ワクチン
• 家禽ワクチン

第7章 動物用/家畜用ワクチン市場：疾患別

• 養殖業
• ペット
• 家畜
• 豚肉
• 家禽

第8章 動物用/家畜用ワクチン市場：技術別

• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• トキソイドワクチン

第9章 南北アメリカの動物用/家畜用ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の動物用/家畜用ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの動物用/家畜用ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aptimmune Biologics, Inc.
• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Brilliant Bio Pharma Private Limited
• Ceva Sante Animale
• China Animal Husbandry Industry Co., Ltd
• Elanco AB
• Endovac Animal Health
• Heska Corporation
• Hester Biosciences Limited
• HIPRA, S.A.
• IDT Biologika GmbH
• Indian Immunologicals Ltd.
• Merck & Co., Inc.
• Phibro Animal Health Corporation
• Torigen Pharmaceuticals Inc.
• Virbac SA
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY/ANIMAL VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY/ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY/ANIMAL VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary/Animal Vaccines Market was valued at USD 8.96 billion in 2023, expected to reach USD 9.58 billion in 2024, and is projected to grow at a CAGR of 6.94%, to USD 14.34 billion by 2030.

The veterinary/animal vaccines market is a crucial segment within the larger animal healthcare industry, focused on preventing infectious diseases among animals through immunization. These vaccines are essential for ensuring the health and productivity of livestock, pets, and wildlife, thus supporting food security, public health, and economic interest. The necessity of animal vaccines is underscored by their role in preventing zoonotic diseases, enhancing animal welfare, and decreasing the reliance on antibiotics, which aids in addressing antimicrobial resistance concerns. Application spans from livestock such as cattle, poultry, and swine to companion animals like cats and dogs, with their primary end-use sectors being animal husbandry, veterinary clinics, and research facilities.

Key growth factors include increasing demand for animal protein, rising pet ownership, and a heightened focus on animal welfare and disease prevention. Additionally, government initiatives to promote vaccination and advancements in biotechnology for developing novel vaccines like DNA or recombinant vaccines contribute significantly to market expansion. Potential opportunities arise from the growing awareness and investment in research and development, aiming to create more effective, affordable, and easily administrable vaccines. Recommendations to capitalize on these opportunities include investing in innovative research, enhancing distribution networks, and focusing on emerging markets with increasing urbanization and disposable incomes.

However, market growth is challenged by factors like stringent regulatory requirements, high costs associated with vaccine development, and a lack of awareness in certain regions. Stability and storage issues, coupled with limited cold chain infrastructure in developing economies, also pose significant barriers. Areas ripe for innovation and research include developing thermostable vaccines, alternative delivery systems such as oral or nanoparticle-based vaccines, and novel adjuvants to enhance immune responses. Understanding the competitive and regulatory landscape, along with consumer preferences, is critical for businesses aiming for growth. The market tends to be dynamic, with continuous innovations and regulatory changes shaping its evolution and presenting both challenges and novel growth opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary/Animal Vaccines Market

The Veterinary/Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Improving veterinary care facilities in economies
  • Rising incidence of chronic diseases and accidental injuries in animals
• Market Restraints
  • High storage costs for vaccines
• Market Opportunities
  • Rising investments in veterinary vaccine R&D
  • Growing availability of pet insurance
• Market Challenges
  • Inadequate surveillance and reporting systems

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary/Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary/Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary/Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary/Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary/Animal Vaccines Market

A detailed market share analysis in the Veterinary/Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary/Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary/Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary/Animal Vaccines Market

A strategic analysis of the Veterinary/Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary/Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., IDT Biologika GmbH, Indian Immunologicals Ltd., Merck & Co., Inc., Phibro Animal Health Corporation, Torigen Pharmaceuticals Inc., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary/Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine, Porcine Vaccine, and Poultry Vaccine.
• Based on Disease, market is studied across Aquaculture, Companion Animal, Livestock, Porcine, and Poultry.
• Based on Technology, market is studied across Inactivated Vaccine, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Improving veterinary care facilities in economies
    • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
  • 5.1.2. Restraints
    • 5.1.2.1. High storage costs for vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising investments in veterinary vaccine R&D
    • 5.1.3.2. Growing availability of pet insurance
  • 5.1.4. Challenges
    • 5.1.4.1. Inadequate surveillance and reporting systems
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary/Animal Vaccines Market, by Type

• 6.1. Introduction
• 6.2. Aquaculture Vaccine
• 6.3. Companion Animal Vaccine
• 6.4. Livestock Vaccine
• 6.5. Porcine Vaccine
• 6.6. Poultry Vaccine

7. Veterinary/Animal Vaccines Market, by Disease

• 7.1. Introduction
• 7.2. Aquaculture
• 7.3. Companion Animal
• 7.4. Livestock
• 7.5. Porcine
• 7.6. Poultry

8. Veterinary/Animal Vaccines Market, by Technology

• 8.1. Introduction
• 8.2. Inactivated Vaccine
• 8.3. Live Attenuated Vaccine
• 8.4. Recombinant Vaccine
• 8.5. Toxoid Vaccine

9. Americas Veterinary/Animal Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary/Animal Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary/Animal Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aptimmune Biologics, Inc.
• 2. Biogenesis Bago SA
• 3. Boehringer Ingelheim International GmbH
• 4. Brilliant Bio Pharma Private Limited
• 5. Ceva Sante Animale
• 6. China Animal Husbandry Industry Co., Ltd
• 7. Elanco AB
• 8. Endovac Animal Health
• 9. Heska Corporation
• 10. Hester Biosciences Limited
• 11. HIPRA, S.A.
• 12. IDT Biologika GmbH
• 13. Indian Immunologicals Ltd.
• 14. Merck & Co., Inc.
• 15. Phibro Animal Health Corporation
• 16. Torigen Pharmaceuticals Inc.
• 17. Virbac SA
• 18. Zoetis Inc.